Trials / Completed
CompletedNCT00158067
Study of an External Responsive Neurostimulator System on Epileptiform Activity
Automated Response to Spontaneous Epileptiform Activity Using the External Responsive Neurostimulator (eRNS) System Clinical Investigation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- NeuroPace · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This feasibility clinical investigation is designed to demonstrate that the NeuroPace external Responsive Neurostimulator (model eRNS-300) can safely deliver responsive electrical stimulation automatically to affect epileptiform activity. The eRNS-300 is based on an implantable neurostimulator that has been adapted for acute, external use in a hospital setting.
Detailed description
The Automated Response to Spontaneous Epileptiform Activity using the External Responsive Neurostimulator (eRNS) system clinical investigation involves subjects who are undergoing intracranial monitoring for the evaluation of epilepsy surgery and who are being monitored in the hospital's epilepsy monitoring unit. During the subject's participation, at the discretion of the investigator, the subject will be connected to the eRNS. The eRNS is an investigational device that attaches to standard intracranial electrode monitoring equipment to monitor the subject's seizure activity. It is anticipated that the subject may be connected to the eRNS for a period of time extending from one day to a few weeks. After the subject has enough seizures to complete their evaluation for epilepsy surgery, the physician may enable the responsive stimulation settings for the eRNS. The subject's participation in the clinical investigation will be complete prior to the removal of their intracranial electrodes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | external Responsive Neurostimulator (eRNS) System |
Timeline
- Start date
- 2002-03-01
- Primary completion
- 2007-04-01
- Completion
- 2008-03-01
- First posted
- 2005-09-12
- Last updated
- 2010-08-26
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00158067. Inclusion in this directory is not an endorsement.